Type 1: IgE immune reaction, immediate hypersensitivity, 5-30 minutes reaction, causes mast cell activation and presents as allergic rhinitis, asthma, or anaphylaxis.
Type 2: IgG/IgM immune reaction, antibody-mediated cytotoxic hypersensitivity, takes minutes to hours for reaction, causes complement mediated phagocytosis and presents as drug allergy, Graves disease, and anemia.
Type 3: IgG/IgM immune reaction, immune complex-mediated hypersensitivity, take 3 to 8 hours for reaction, causes tissue damage induced by immune complexes, and presents as rheumatoid arthritis, serum sickness, and SLE.
Type 4: T cell reaction, cell-mediated hypersensitivity, takes 48 to 72 hours for reaction, causes T cell mediated inflammation or cytotoxicity and presents as contact dermatitis, graft rejection, and chronic asthma.
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.